James McCarty

About

James W. McCarty is an interdisciplinary scholar specializing in Peace Studies and Christian Ethics. His research focuses on the ethics of social and political practices of social transformation, including restorative justice, grassroots peacebuilding, nonviolent social change, and racial justice and human rights activism. He has written about the theological ethics of Martin Luther King Jr. and Desmond Tutu and has published essays on Asian American Christian Ethics. Dr. McCarty is a general editor of the book series The Business of Modern Life, which critically examines the influence of neoliberal capitalism on shared life. Prior to his appointment at Boston University, he held administrative and teaching positions at Emory University, Seattle University, and the University of Washington. At BU, he teaches courses in conflict transformation, restorative justice, peacebuilding, and community organizing, and administers the Certificate in Religion and Conflict Transformation in collaboration with the Boston Theological Interreligious Consortium. In addition to his academic work, Dr. McCarty has served as a minister and has worked in congregational and campus ministries across Washington, Georgia, and California. He has also been involved as a practitioner in restorative justice, transformative justice, and conflict transformation in the United States and East Africa.

Research topics

• Medicine
• Immunology
• Internal medicine
• Biology
• Gastroenterology
• Surgery
• Dermatology
• Virology

Selected publications

• Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial

  The Lancet Infectious Diseases · 2022 · 73 citations

  PublisherDOI

• Extrapulmonary Coccidioidomycosis Among Children in Central California

  The Pediatric Infectious Disease Journal · 2019-11-18 · 19 citations

  review

  BACKGROUND: The literature on pediatric extrapulmonary coccidioidomycosis is limited. We reviewed the clinical course, diagnostic studies, treatment and outcomes of children with extrapulmonary coccidioidomycosis followed at a tertiary care center in central California. METHODS: Retrospective study of 78 patients ≤21 years old with extrapulmonary coccidioidomycosis diagnosed over 10 years (1/1/07-12/31/16). RESULTS: The median age was 9.7 years (interquartile range, 4.5-14.8). The majority of pa…

  PublisherDOI

• Isavuconazole as Salvage Therapy for Refractory Pediatric Coccidioidal Meningitis

  The Pediatric Infectious Disease Journal · 2020 · 15 citations

  Senior authorCorresponding

  Coccidioidal meningitis remains difficult to treat. The newer triazole, isavuconazole, has demonstrated efficacy in invasive fungal disease with less side effects than other azoles. We describe a case of refractory pediatric coccidioidal meningitis with disease stabilization and improvement on isavuconazole after failing treatment with other antifungal agents.

  PublisherDOI

• Elevated regulatory T cells at diagnosis of Coccidioides infection associates with chronicity in pediatric patients

  Journal of Allergy and Clinical Immunology · 2018-10-26 · 15 citations

  letter
  PublisherDOI

• Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study

  The Lancet Microbe · 2025-02-12 · 12 citations

  articleOpen access

  BACKGROUND: Immune responses to alphavirus vaccines might be impaired when heterologous alphavirus vaccines are administered sequentially. We aimed to compare immunogenicity and safety of a chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of heterologous alphavirus vaccines with alphavirus-naive controls in the USA. METHODS: -transformed titre as the dependent variable, and study arm, age, and sex as predictors. Least squares means, difference, and 95% CIs were ba…

  PublisherDOI

Frequent coauthors

• Jack W. Singer

  37 shared

• Richard T. Maziarz

  Oregon Health & Science University

  37 shared

• James R. Mason

  United States Army

  37 shared

• Yuan‐Di C. Halvorsen

  37 shared

• V. Annino

  37 shared

• E. Anaissie

  University of Arkansas for Medical Sciences

  37 shared

• William F. Hahne

  37 shared

• R.M. Rifkin

  Rocky Mountain Cancer Centers

  37 shared

Similar researchers at Stanford University

• Laurel C. Schneiderh-82
• Peng Yinh-72
• Steven J. Sandageh-37